Introduction
The c-myc proto-oncogene encodes a nuclear phosphoprotein, namely a DNA sequence-speci®c transcriptional factor, which forms dimers with a related polypeptide, Max, to optimize the binding to DNA (Cole, 1986; Spencer and Groudine, 1991; Blackwood and Eisenman, 1991; Marcu et al., 1992) . Appropriate regulation of expression of c-myc is necessary for normal cellular proliferation, dierentiation and progression of the cell cycle, and deregulation of the expression of c-myc is associated with tumorigenesis and apoptosis (Cole, 1986; Marcu et al., 1992) . Regulation of c-myc occurs at multiple levels, which include the initiation of transcription, the termination of transcription, and the attenuation of transcription (Spencer and Groudine, 1991; Marcu et al., 1992) . In proliferating cells, the initiation of transcription of the c-myc gene is regulated by P1 and P2 promoters and the RNA initiated from the P2 promoter accounts for 80 ± 90% of the total RNA initiated from the P0, P1 and P2 promoters DesJardins and Hey, 1993) . Optimal initiation of transcription from the P2 promoter requires the ME1a2, E2F and ME1a1 elements in the P2 promoter (Moberg et al., 1991 . Several transcriptional factors, including Sp1 (DesJardins and Hey, 1993; Ash®eld et al., 1994) , and the zinc-®nger protein ZF87/MAZ (a zinc-®nger protein of 87 kDa; Pyrc et al., 1992; Bossone et al., 1992; DesJardins and Hey, 1993) or a mouse homolog Pur-1 (purine-binding factor; Kennedy and Rutter, 1992) and E2F (Kovesdi et al., 1986) bind to these elements in vitro and in vivo. The Myc-associated zinc ®nger protein (MAZ) was identi®ed as a transcriptional factor that bind to a GA box (GGGAGGG) at the ME1a1 site, to the attenuator region of P2 within the ®rst exon of the c-myc gene, and to a related sequence that is involved in the termination of transcription of the gene for complement 2 (C2) (DesJardins and Hey, 1993; Bossone et al., 1992) . Kennedy and Rutter (1992) found that the Pur-1 protein bound to the GAGA boxes of rat genes for insulin I and II and of the human gene for islet amyloid polypeptide. Recently, we reported isolation of a cDNA clone for a member of the family of MAZ proteins in human islet cells that had a similar DNA-binding speci®city (Tsutsui et al., 1996) . A MAZ plays a role in the control of the initiation of transcription of genes for CD4 (Duncan et al., 1995) and serotonin (Parks and Shenk, 1996) and in the termination of transcription between closely spaced human genes for complement (Ash®eld et al., 1994) and also between the introns of the mouse gene for IgM-D (Ash®eld et al., 1994) . Therefore, MAZ appears to be a transcriptional factor with a dual role in the initiation and termination of transcription.
In this study we examined the role of MAZ protein in the expression of the c-myc gene during the neuroectodermal dierentiation of mouse P19 embryonal carcinoma (EC) cells. P19 cells can be induced to dierentiate into neurons, astrocytes and ®broblasts by exposure to retinoic acid (RA). By contrast, P19 cells treated with dimethyl sulfoxide (DMSO) dierentiate into cardiac and skeletal muscle cells McBurney et al., 1982; Edwards et al., 1983) . In the presence of RA, transcription of the cmyc gene during the dierentiation of P19 cells increases transiently and biphasically: ®rst after 3 h and then from 48 h to 96 h. However, the latter increase does not occur in the case of induction with DMSO (St-Arnaud et al., 1988) . The ®rst peak in the level of c-myc mRNA at 3 h is associated with an increase in the stability of the mRNA without any change in either the extent of transcription or the utilization of promoters, as assessed by nuclear run-on assays (St-Arnaud et al., 1988) . Thus, the increase in the stability of c-myc mRNA appears to be responsible for this early increase in the level of c-myc mRNA. By contrast, the stability of c-myc mRNA at 48 and 96 h is similar to that in untreated cells. However, a ®vefold increase has been demonstrated in the rate of transcription of exons 1, 2 and 3 of the c-myc gene after 48 h of treatment with RA (St-Arnaud et al., 1988) . Thus, the second peak of expression of c-myc mRNA seems to be due to the increased rate of transcription of the c-myc gene. However, the transcriptional factors required for the regulation of the rate of transcription of the c-myc gene have not yet been identi®ed.
In the present study, we found that at least the ME1a1 element in the P2 promoter of the c-myc gene is necessary for the second increase in the expression of c-myc mRNA that occurs during the neuroectodermal dierentiation of P19 cells and, moreover, that the MAZ protein, bound to the ME1a1 element, seems to be associated with this aspect of the regulation of transcription of the c-myc gene.
Results
The ME1a1 element is essential for the transcription of the c-myc gene during RA-induced dierentiation To determine whether the ME1a1 element in the P2 promoter aects the expression of the c-myc gene during the dierentiation of P19 cells, we cotransfected P19 cells with a DNA fragment that consisted of the 5'-region of the c-myc gene fused to a CAT reporter gene (Figure 1a) or to a mutant CAT derivative that lacked the ME1a1 site, together with pSV2neo. After selection with G418 for 3 weeks, we obtained several hundred stable transformed clones. Representative transformed clones such as pMyc1 and pMyc2, respectively, were treated with RA at 10 76 M for dierent lengths of time, and then the level of expression of the CAT reporter gene was measured (Figure 1b) . The expression of pMyc2CAT fell ®vefold within 24 h upon exposure of cells to RA; it returned to the normal level within 48 h and it decreased again to below 20% of the normal level after 96 h (Figure 1b , lanes 9 ± 16). The expression of pMyc1CAT did not return to the normal level within 48 h in the presence of RA (Figure 1b , lanes 1 ± 8). We did not detect an initial increase in CAT activity 1 ± 6 h after the start of treatment with RA ( Figure 1b , lanes 10 and 11). These results indicate that the ME1a1 element is necessary for the transient increase in transcription of the c-myc gene that occurs 48 h after the addition of RA during the neuroectodermal dierentiation of P19 cells.
We next analysed the expression of the c-myc gene during the RA-induced dierentiation of P19 cells by Northern blotting (Figure 1c ). As expected, the level of the transcript of the c-myc gene was depressed 7 ± 8-fold at 18 to 24 h, it returned to the initial level at 48 h and it decreased again 5 ± 6-fold at 96 h in the presence of RA, as compared to the level of c-myc mRNA in undifferentiated P19 cells (Figure 1c , lanes 1 ± 5). By contrast, the level of expression of the gene for b-actin remained unchanged (Figure 1c , lanes 6 ± 10).
We also examined the eect of the MAZ protein on the promoter activity of the c-myc gene by transforming cells with a c-myc promoter/CAT reporter construct, pMyc2CAT; a mutant variant construct, pMyc1CAT; and pICAT, as the control plasmid (Kitabayashi et al., 1991) . As shown in Figure 1d , the CAT activity of cells transformed with the c-myc promoter/CAT construct with the ME1a1 site was increased 2 ± 3-fold by MAZ protein (lanes 6 and 7), while the CAT activity of cells transformed with the cmyc promoter/CAT construct without the ME1a1 site was not (lanes 4 and 5). These results indicate that the MAZ protein can aect the ME1a1 site-mediated regulation of expression of the c-myc gene in P19 cells.
No changes were detected in the expression of MAZ mRNA and protein during RA-induced dierentiation As shown in Figure 1 , the ME1a1 element in the P2 promoter of the c-myc gene was essential for the second increase in the level of expression of the c-myc gene during the dierentiation of P19 cells. To determine whether the expression of c-myc is regulated by MAZ, we prepared total RNAs from P19 cells that had been treated with RA at 10 76 M for dierent lengths of time and analysed it by Northern blotting with MAZ cDNA as probe (Figure 2a) . Transcripts of the gene for MAZ of approximately 1.6, 2.6 and 4.5 kb were detected and the levels of these mRNAs did not change during the dierentiation of P19 cells ( Figure  2a , lanes 1 ± 8). Furthermore, to examine the changes in expression of MAZ protein during the dierentiation, we prepared lysates of P19 cells that had been treated with RA at 10 76 M for dierent lengths of time, and analysed the proteins by Western blotting with antibodies speci®c for MAZ (Figure 2c ). Two major proteins of 58 ± 60 kD and 38 kD were detected with antibodies against MAZ protein. The 38 kDa protein appeared to be generated from the internal methionine codon that starts at nt 857 in the coding region, as described previously (Tsutsui et al., 1996) . No changes in the levels of these proteins were seen during the dierentiation of P19 cells (Figure 2c , lanes 2 ± 5). Moreover, the preimmune serum did not generate any bands of proteins on Western blots (Figure 2c , lanes 6 ± 9).
MAZ binds to the ME1a1 element
We showed that the ME1a1 element in the promoter of the c-myc gene was necessary for the second increase in level of the transcript of the c-myc gene during the neuroectodermal dierentiation of P19 cells ( Figure  1b ). By contrast, the levels of both the MAZ protein and MAZ mRNA did not change to any signi®cant extent (Figure 2a and c) . Therefore, we next examine the DNA-binding activity of MAZ to the ME1a1 element of the c-myc gene. Nuclear extracts of undierentiated P19 cells were prepared and analysed in an electrophoretic mobility shift assay (EMSA) with the double-stranded ME1a1 sequence as probe ( Figure  3a ). As shown in lane 2 of Figure 3b , three shifted bands were detected. The three bands disappeared after the addition of the unlabeled competitor oligodeoxynucleotide that corresponded to the sequence of the ME1a1 element (lanes 3 and 4). However, the shifted bands were unchanged after addition of the mutant oligodeoxynucleotide as competitor (lanes 6 and 7). Unrelated antibodies, raised against c-jun/AP-1, did not alter the mobility of the shifted bands of DNAprotein complexes (lane 8). It has been reported that 8 and 9 ), pMyc1CAT (lanes 2, 4 and 5) or pMyc2CAT (lanes 3, 6 and 7), 2 mg of pSV2neo and 3 mg of pCH110 were used to transfect P19 cells together with (lanes 4 ± 9) or without (lanes 1 ± 3) 5 mg of the pCMV-MAZ expression vector. After selection with G418 for 3 weeks, stably transformed independent clones were isolated. Lysates were prepared and analysed for CAT activity as described in Materials and methods the ME1a1 element is recognized by MAZ and by the transcriptional factor Sp1 (DesJardins and Hey, 1993; Ash®eld et al., 1994) . In an attempt to characterize the proteins that bound to the ME1a1 element, we added monoclonal antibodies against MAZ and polyclonal antibodies against Sp1 to reaction mixtures for the EMSA. The monoclonal antibodies against MAZ shifted the retarded band still further (Figure 3b , lane 5). However, the antibodies against Sp1 did not aect the mobility of the DNA-protein complexes ( Figure 3b , lane 8; Figure 3c , lane 4). Moreover, we used puri®ed Sp1 protein from Hela cells for an EMSA with the double-stranded ME1a1 as probe and no retarded bands were detected on the gel (Figure 3c , lane 5).
To investigate the binding of the MAZ protein to the ME1a1 element during the neuroectodermal dierentiation of P19 cells, we prepared nuclear extracts of P19 cells that had been treated with RA at 10 76 M for dierent lengths of time. We incubated the extracts with a 32 P-labeled double-stranded oligodeoxynucleotide probe that corresponded to the ME1a1 site and analysed the mixture by EMSA (Figure 4a ). The anity of the MAZ protein for the ME1a1 site declined after 24 h in the presence of RA, as compared to the binding anity of MAZ from undierentiated P19 cells (compared complex C in lanes 2 and 3). The level of the DNA-protein complex that corresponded to band C returned to the normal level after 48 h (lane 4), and it fell again from 72 h to 96 h (lanes 5 and 6). We determined the relative (Figure 4b ). The level of complex C decreased to approximately 60% of the initial level after 24 h in the presence of RA and then it returned to the original level at 48 h. Finally, it decreased again to 35 ± 40% of the initial amount of the DNA-protein complex (Figure 4b ). These results indicate that the binding of MAZ protein to the ME1a1 element was altered during the dierentiation of P19 cells and the change in the binding of MAZ to the ME1a1 element, in particular the change in the binding that generated complex C, corresponded to the changes in the regulated expression of the c-myc gene during the neuroectodermal dierentiation of the P19 cells.
Discussion
The RA-mediated dierentiation of P19 cells into various types of cells derived from the neuroectoderm is associated with a biphasic increase in the steadystate levels of c-myc mRNA and protein (St-Arnaud et al., 1988) . The ®rst peak in the expression of the cmyc gene at 3 h might be associated with the induction of dierentiation of P19 cells by RA . Dierentiated neurons appear in RA-treated cultures between 3 and 5 days after the start of treatment with RA . The second peak in c-myc expression, from 2 ± 4 days, appears slightly to precede this event, suggesting that elevated levels of c-myc mRNA and protein might occur in neuroblast cells just prior to their differentiation into post-mitotic neurons. However, it is not yet known whether the late increase and decrease in levels of c-myc mRNA and protein occur in only these cells that are destined to dierentiate into neurons. The period from 48 h to 96 h is equivalent to the so-called the commitment phase of dierentiation. That is, a large number of cells progress to a stable dierentiated phenotype after this phase, even in the absence of any dierentiation-inducing agents . The temporal correlation between these late changes in the chromatin, the initiation of transcription and the reversibility of the down-regulation of the c-myc gene is intriguing. The down-regulation of the cmyc gene in an essential component of dierentiation, as reported in other systems (Lachman et al., 1986; Prochownik and Kukowska, 1986; Yokoyama and Imamoto, 1987; WickstroÈ m et al., 1988; Holt et al., 1988) . The constitutive expression of a transfected cmyc gene prevents the dierentiation of mouse erythroleukemia cells (Coppola and Cole 1986; Dmitrovsky et al., 1986; Lachman et al., 1986; Prochownik and Kukowska, 1986; Kume et al., 1988) , but its critical function has not been well documented. Moreover, the biphasic transient accumulation of c-myc mRNA in P19 cells that have been treated with 1610
76 M RA appears to be well correlated with dierentiation in the neuroectodermal lineage Edwards and McBurney, 1983) . Neither treatment with a lower concentration of RA nor induction with DMSO induce such a biphasic increase in the accumulation of c-myc mRNA and the appearance of the neuronlike phenotypes. As shown in Figure 5 , 20 ± 30% of P19 cells treated with RA developed neural ®laments that could be stained with antibodies speci®c for a 160 kDa neural ®lament protein. A systematic study of the phases of dierentiation of P19 cells using a lower concentration of RA indicated that the second increase in the level of c-myc mRNA is well correlated with neural dierentiation (Edwards and McBurney, 1983; St-Arnaud et al., 1988) . These results prompted us to attempt to de®ne the role of the second increase in expression of the c-myc gene in the dierentiation of P19 cells. We found here that the second increase in the level of c-myc mRNA was associated with the activation of transcription of the c-myc gene via the ME1a1 site in the c-myc promoter after 48 h of treatment with RA (Figure 1 ). Moreover the DNA-binding activity of MAZ protein to ME1a1 was well correlated with the ME1a1-mediated promoter activity of the c-myc gene (Figures 1b and 3b) . However, we did not detect an initial peak of CAT activity under control of the c-myc promoter between 1 and 6 h after the start of exposure of RA, a result that does not re¯ect the changes in the level of c-myc mRNA as reported previously ( Figure  1b ; St-Arnaud et al., 1988) . This result indicates that the ®rst increase in level of c-myc mRNA was due not only to the ME1a1-mediated transcription but also to the post-transcriptional regulation of the expression of the c-myc gene.
Three distinct elements, ME1a2, E2F and ME1a1, within the P2 promoter of the c-myc gene are located at positions +65 ± 88, +98 ± 105 and +112 ± 121 respectively, relative to the P1 promoter (Asselin et al., 1989; Hall, 1990) and they required for optimal transcription of the c-myc gene (Moberg et al., 1991 , in addition to the consensus TATA box. It was reported that the ME1a1 element had a small positive eect on the initiation of transcription in a study in vitro (Hall, 1990) and was necessary for P2 promoterdependent transcription in vivo (Asselin et al., 1989) . Moberg et al. (1992) reported that, individually, the three elements ME1a2, E2F and ME1a1 are weak, but together they contribute to full promoter activity. As shown in Figure 3b (lanes 6 and 7) , the formation of the DNA-protein complex was not subject to any competition when the oligonucleotide added as a potential competitor was changed from CGGAGGG, the ME1a1 element, to CGGATTG, which is not recognized by MAZ (Wong et al., 1995) . Moreover, ectopic expression of MAZ protein in P19 cells resulted in a small but signi®cant increase in the CAT activity due to the pMyc2CAT reporter gene, while such was not the case with the pMyc1CAT deletion construct (Figure 1d, lanes 4 and 5) . These results imply that the ME1a1 element, at least, is critical for the transient second increase in expression of the c-myc gene that occurs during the RA-induced dierentiation of P19 cells. However a direct association between the increase in c-myc mRNA and the induction of the differentiation of P19 cells remains to be proven.
Let us consider now the transcription factor(s) that bind to the ME1a1 element of the c-myc promoter a b during the dierentiation of P19 cells. We detected three speci®c DNA-protein complexes, namely, A, B and C (Figure 3b , lane 2). Previous reports showed that the ME1a1 element is recognized not only by MAZ but also by the transcriptional factor Sp1 (DesJardins and Hey, 1993; Ash®eld et al., 1994) .
With the exception of a single base within the ME1a1 element, this element is conserved in the mouse, rat and human homologs of the c-myc gene (Moberg et al., 1991) . The same or a very closely related protein in the extracts of Hela cells bound to both the ME1a1 and ME1a2 elements . The regulation of the c-myc gene is complex since a number of transcriptional factors, as well as both transcriptional and post-transcriptional regulation, are involved . However, we found here that antibodies speci®c for MAZ but not for Sp1 caused shifted bands on a gel in EMSA (Figure 3b) . Moreover, puri®ed Sp1 protein from Hela cells did not bind to the probe that corresponded to ME1a1 (Figure 3c ). These results indicate that MAZ protein might be important for ME1a1-mediated expression of c-myc gene after 48 h of treatment of P19 cells with RA. The DNA complexes A, B and C observed with the ME1a1 probe were all super-shifted after addition of antibodies against MAZ protein (Figure 3b , lane 5). In turn, MAZ activated the initiation of transcription of the c-myc gene in P19 cells (Figure 1d ). It was reported that the forced expression of MAZ was not associated with a signi®cant increase in the level of cmyc mRNA in NIH3T3 cells (Pyrc et al., 1992) . However, we demonstrated a weak but signi®cant enhancement of the activity of the promoter of the cmyc gene by MAZ protein (Figure 1d ). The levels of MAZ mRNA and protein did not change signi®cantly during the dierentiation of P19 cells (Figure 2 ). By contrast, the kinetics of changes in the DNA-binding anity of MAZ for the ME1a1 element (band C) were closely correlated with the kinetics of the changes in level of expression of c-myc mRNA and in the promoter activity of the c-myc gene during the dierentiation of P19 cells (Figures 1b and c) . Therefore, it seems likely that some modi®cation of MAZ, such as phosphorylation, might be responsible for the change in the DNA-binding activity of MAZ. A previous study demonstrated that the MAZ protein is phosphorylated in COS cells, possibly on serine and threonine residues (Pyrc et al., 1994) . Similarly, in our preliminary study of DNA binding in vitro, phosphorylation by casein kinase (CKII) signi®cantly enhanced the DNA-binding activity to the NHE (nucleasehypersensitive element)-III 2 , as compared with that of unphosphorylated MAZ protein (data not shown). Treatment of neuroblastoma cells with an antisense oligodeoxynucleotide speci®c for the gene for CKII blocked neuritogenesis (Ullow et al., 1993) . Changes in the extent of phosphorylation by CKII during dierentiation of neuroblastoma cells might aect the DNA-binding activity of certain transcription factors, including MAZ (Ullow et al., 1993) . However, we cannot rule out the possibility that other factors might associate with MAZ and aect the regulation of transcription of the c-myc gene. Preliminary studies with u.v.-crosslinking, treatment of the DNA-protein complex with deoxycholate (DOC) and the`reversed' combination of immunoprecipitation with antibodies speci®c for MAZ protein and a subsequent gel shift assay tend to support the presence of the other associated factors with MAZ (data not shown). The ME1a1-mediated transcription of the c-myc gene that involves the MAZ protein is associated with a transient second increase in the level of c-myc mRNA after a 48 h incubation of P19 cells in the presence of RA, which seems to be well correlated with the dierentiation of these cells into neuroectoderm. The molecular mechanism of the interaction of MAZ protein with other factors, including E2F or other factors that bind to the ME1a2 site, and the way in which these factors function to stabilize the interaction of MAZ with E2F, with or without other eective proteins, are totally unknown. An understanding of the mechanism of the binding of MAZ protein to these proximal and distal sites and the subsequent regulation of transcription of the c-myc gene after 48 h of exposure of P19 cells to RA should shed more light on the mechanisms that control the dierentiation of P19 cells to neuroectoderm.
Materials and methods
Plasmids pCMV-MAZ was constructed as described previously (Tsutsui et al., 1996) . The pMyc2CAT reporter was generated by insertion of the DNA fragment from 7187 to +412 relative to the P1 site of initiation of transcription into the SpeI ± HindIII site of pICAT (Kitabayashi et al., 1991) . The pMyc1CAT was generated by deletion from pMyc2CAT of the DNA fragment from +112 to +121 relative to the P1 initiation site.
Cell culture, transfection and CAT assay P19EC (P19) cells were grown in a-MEM (GIBCO BRL, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (GIBCO BRL) and 60 mg/ml kanamycin monosulfate (Sigma Chemical Co., St Louis, MO, USA). Retinoic acid (Sigma Chemical Co.) for induction of dierentiation was added to cultured cells in monolayers at 1610 76 M. For induction of neural dierentiation of P19 cells, cells were cultured in bacteriological-grade dishes (Becton Dickinson, Franklin Lakes, NJ, USA) in the presence of RA at 1610 76 M for 2 days, transferred to tissue culture-grade dishes (Corning, Corning, NY, USA), and cultured in the absence of RA for another 2 days as described elsewhere McBurney et al., 1982; Edward et al., 1983) . Transient and stable transfections and assays of chloramphenicol acetyltransferase (CAT) activity were performed as described elsewhere (Kitabayashi et al., 1992) . The extent of conversion of chloramphenicol to its acetylated form was determined with a Bio-Imaging analyzer (model BAS 2000; Fuji, Tokyo, Japan). b-Galactosidase activity was assayed as described by Kitabayashi et al. (1992) . The ratio of CAT activity to the activity of b-galactosidase was used for normalization of results.
Isolation of RNA and Northern hybridization
Total RNA (10 mg) from P19 cells that had been cultured in the presence or absence of RA at 1610 76 M for dierent lengths of time was isolated and fractionated on a formaldehyde-1% agarose gel and transferred to a nylon membrane as described elsewhere (Tsutsui et al., 1996; Sambrook et al., 1989) . The blot was allowed to hybridize with a 1.8 kb EcoRI DNA fragment derived from pCMV-MAZ (Tsutsui et al., 1996) or a 2.3 kb BamHI DNA fragment derived from pC5-8 c-myc expression vector (Yokoyama and Imamoto, 1987) . The DNA probe was labeled with a-32 P-dCTP by the random-priming method (Feinberg and Vogelstein 1983) .
Immunoblot analysis
Whole-cell lysates were prepared as described elsewhere (Kawasaki et al., 1996) . Immunoblotting was performed by the standard protocol as described elsewhere (Kaufmann et al., 1987) . In brief, proteins were fractionated on an SDSpolyacrylamide gradient (2 ± 15%) multigel (Daiichi Pure Chemicals Co., Tokyo, Japan) and then transferred to Immunobilon PVDF-nylon membrane (Daiichi Pure Chemicals). The membrane was blocked with 5% nonfat milk in phosphate-buered saline (PBS-T; 0.2% Tween 20 in phosphate-buered saline, PBS (7) ) for 1 h at 258C and then washed four times with PBS-T. It was then incubated with 1000-fold diluted polyclonal antibodies against MAZ in 1% BSA in PBS-T overnight at 48C and then washed four times with PBS-T. Antibodies bound to the membranes were detected with horseradish peroxidase (HPR)-conjugated antibodies against rabbit immunoglobulin G (Zymed Laboratories, San Francisco, CA, USA) and a chemiluminescence kit (Dupont NEN, Boston, MA, USA).
Preparation of nuclear extracts and the electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared as described elsewhere (Schmitt-Ney et al., 1991; Ye et al., 1996) . P19 cells were treated with 300 ml of lysis buer (50 mM KCl, 0.5% Nonidet P-40 (NP-40), 25 mM HEPES (pH 7.8), 1 mM phenylmethanesulfonyl¯uoride (PMSF), 10 mg/ml leupeptin, 10 mg/ml pepstatin, 20 mg/ml aprotinin, 100 mM dithiothreitol (DTT) on ice for 4 min. The supernatant was saved after centrifugation at 40 000 g for 1 min at 48C. The nuclei were washed once with the same volume of buer without NP-40 and then placed in 100 ml of extraction buer (500 mM KCl and 10% glycerol with the same concentrations of HEPES (pH 7.8), PMSF, leupeptin, aprotinin and DTT as those in the lysis buer). After centrifugation at 40 000 g for 5 min at 48C, the supernatant was harvested as the nuclear extract. Protein concentrations were determined with bicinchoninic acid (BCA; Pierce, Rockford, III.). For EMSA, the reaction was conducted in 25 ml of a reaction mixture that included 3 mg of poly dI.dC (Sigma Chemical Co.), 5 mg of nuclear protein, 1610 4 c.p.m. of 32 P-labeled double-stranded oligodeoxynucleotide that corresponded to the ME1a1 site, and 5 ml of 56binding buer (50 mM HEPES (pH 7.8), 250 mM KCl, 5 mM EDTA (pH 8.0), 25 mM MgCl 2 , 50% glycerol, 25 mM DTT, 3.5 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml pepstatin, and 10 mg/ml leupeptin). In some cases, a double-stranded oligodeoxynucleotide as competitor or antibodies against MAZ (Tsutsui et al., 1996) or against c-jun/AP-1 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) or against Sp1 (Santa Cruz Biotechnology Inc.) were added to the reaction mixture. The puri®ed Sp1 protein from Hela cells was obtained from Santa Cruz Biotechnology Inc. The mixture was incubated on ice for 5 min, and incubation was continued at 48C for 6 h without or with antibodies, then it was incubated for 25 min at 258C in the presence of a 32 P-labeled double-stranded oligodeoxynucleotide and ®nally resolved on a 4.5% polyacrylamide gel that had been prerun at 110 V for 2 h in 0.256TEA buer (40 mM Tris (pH 7.8), 1.1 mM EDTA, 37 mM sodium acetate (pH 8.0)). Electrophoresis of the loaded gel was performed at 200 V for 90 min, and then the gel was dried and subjected to autoradiography on X-Omat ®lm (Eastman Kodak Company, Rochester,USA) at 7808C. We determined the radioactivity of complex C relative to the total radioactivity of the DNA probe. The normalized radioactivity of the DNA-protein complex that corresponded to band C from the extract of undierentiated P19 cells was taken arbitrarily as 100% (12.5% of the total radioactivity was shifted on the gel). Each cited result represents the mean+s.d.) of results from four experiments.
Immunohistochemical staining
Immunohistochemical staining was performed to determine the phenotypic features of the dierentiated P19 cells. Cells, plated on a glass coverslip, were cultured in the presence or absence of RA at 378C and ®xed in precooled methanol at 7208C. Cells on coverslips were washed with phosphate-buered saline plus 0.05% Tween 20-(PBS-T), incubated in blocking solution that contained 0.05% Tween 20 and 1% BSA for one hour at room temperature, and then incubated with monoclonal antibodies against neuro®lament 160 kDa protein (NF-160K) (Boehringer-Mannheim, Mannheim, Germany) that had been diluted 1: 200 in 1% BSA in PBS-T for 2 h at room temperature. After several washes with PBS-T, the sample was incubated with 500-fold diluted biotin-conjugated rabbit antibodies against mouse IgG (Zymed Laboratories) in blocking solution that contained 3,3'-diaminobenzidine (Sigma). Photographs were taken with a PM-30 automatic system (Olympus, Tokyo; photomicrographs6200).
